Daniel Janman

Statistics

Publications

Citations

501

H-Index

Active since

2017

Affiliations

University College London(Current)

The Royal Free Hospital

University of Birmingham

Daniel Janman is an author at University College London specializing in cytotoxic t-lymphocyte antigen 4 (ctla-4) pathway, life sciences, and immunology.

ORCID

Publications per year

2017–2022

Publications

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Alan Kennedy, Erin Waters, Behzad Rowshanravan et al. · Nature Immunology · 2022 · 212 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations

Tie Zheng Hou, Nisha Verma, Jennifer Wanders et al. · Blood · 2017 · 100 citations · Full text

Life Sciences, Genetics, Immunology +16

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4

Neil Halliday, Cayman Williams, Alan Kennedy et al. · Frontiers in Immunology · 2020 · 92 citations · Full text

Life Sciences, Cell Biology, Immunology +17

CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis

Blagoje Soskic, Louisa Jeffery, Alan Kennedy et al. · Frontiers in Immunology · 2021 · 50 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Regulation of CTLA‐4 recycling by LRBA and Rab11

Daniel Janman, Claudia Hinze, Alan Kennedy et al. · Immunology · 2021 · 47 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

1–5 of 5